129593-20-0 Usage
General Description
(2S,3S)-3-Amino-2-Hydroxy-4-Phenylbutyric Acid Hydrochloride is a chemical compound that consists of an amino group, a hydroxyl group, and a phenylbutyric acid group. It is the hydrochloride salt form of the compound, making it more stable and suitable for use in pharmaceutical applications. (2S,3S)-3-Amino-2-Hydroxy-4-Phenylbutyric Acid Hydrochloride has potential biological activity and may be used as a precursor or intermediate in the synthesis of various drugs and pharmaceuticals. It is important to handle and store this compound with proper safety precautions, as it is a potent chemical substance. Overall, (2S,3S)-3-Amino-2-Hydroxy-4-Phenylbutyric Acid Hydrochloride has potential uses in the pharmaceutical industry and may have various applications in drug development and synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 129593-20-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,5,9 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 129593-20:
(8*1)+(7*2)+(6*9)+(5*5)+(4*9)+(3*3)+(2*2)+(1*0)=150
150 % 10 = 0
So 129593-20-0 is a valid CAS Registry Number.
129593-20-0Relevant articles and documents
Synthesis of α-Ketoamide-Based Stereoselective Calpain-1 Inhibitors as Neuroprotective Agents
Jastaniah, Ammar,Gaisina, Irina N.,Knopp, Rachel C.,Thatcher, Gregory R. J.
, p. 2280 - 2285 (2020/09/23)
Calpain inhibitors have been proposed as drug candidates for neurodegenerative disorders, with ABT-957 entering clinical trials for Alzheimer's disease and mild cognitive impairment. The structure of ABT-957 was very recently disclosed, and trials were te
A Practical Synthesis of threo-3-Amino-2-hydroxycarboxylic Acids
Matsuda, Fuyuhiko,Mtsumoto, Teruyo,Ohsaki, Masako,Ito, Yoshio,Terashima, Shiro
, p. 360 - 365 (2007/10/02)
An expeditious synthesis of (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutyric acid (2) and (2S,3R)-3-amino-2-hydroxy-4-phenylbutyric acid (4), the key components of the renin inhibitor (1) and bestatin (3), respectively, have been accomplished by featuring hi
